文献速递心境障碍

监测抑郁个体症状早期改善预测抗抑郁药反应:个体患者数据荟萃分析

Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis.
PubMed 文献 · Br J Psychiatry · 2018-06-28

该研究纳入30项试验的2184例安慰剂组和6058例抗抑郁药组个体患者数据,比较仅含第2周总分改善与额外含个体症状改善的模型对第6周反应、缓解及第12周结局的预测能力。结果显示个体症状模型预测第6周反应的AUC为0.77,仅略高于总分模型的0.73,且第12周预测性能下降;早期未改善者中29%第6周实际仍反应、43%第12周反应。结论认为检查个体症状对早期改善预测能力提升有限,早期未改善不能排除后续反应或缓解。

要点

  • 个体症状改善模型预测第6周反应AUC 0.77,仅略优于总分模型0.73。
  • 早期未改善者中29%第6周、43%第12周实际仍达到反应。
  • 仅因早期改善有限而常规调整药物治疗可能为时过早。

核心结论

  • 检查个体抑郁症状对早期改善预测反应或缓解的能力提升有限。
  • 早期未改善不能排除第6周或第12周的反应或缓解,尤其第12周。
  • 因早期改善有限而常规调整药物治疗可能常常为时过早。

研究设计与样本

  • 个体患者数据荟萃分析,纳入30项试验共2184例安慰剂组和6058例抗抑郁药组参与者。
  • 主要结局为第6周反应,次要结局为第6周缓解及第12周反应和缓解。
  • 比较仅含第2周总分改善的模型与额外含个体症状改善的模型。

主要发现

  • 第6周反应:总分改善模型AUC 0.73、阴性预测值0.67、阳性预测值0.74;个体症状模型分别为0.77、0.70、0.71。
  • 第12周结局的模型性能下降。
  • 预测为非反应者中,29%第6周实际反应、43%第12周实际反应,低于基线总体概率51%和69%。
  • 事后分析采用连续而非二分早期改善时,纳入个体条目未增强模型性能。

临床怎么用

  • 不应仅因第2周改善有限就常规调整药物治疗方案。
  • 早期未改善者仍可能在后续第6周或第12周达到反应或缓解。

局限性

  • 第12周结局的模型预测性能下降。
  • 事后分析采用连续早期改善时个体条目未增强模型性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improvement in depression within the first 2 weeks of antidepressant treatment predicts good outcomes, but non-improvers can still respond or remit, whereas improvers often do not.AimsWe aimed to investigate whether early improvement of individual depressive symptoms better predicts response or remission. METHOD: We obtained individual patient data of 30 trials comprising 2184 placebo-treated and 6058 antidepressant-treated participants. Primary outcome was week 6 response; secondary outcomes were week 6 remission and week 12 response and remission. We compared models that only included improvement in total score by week 2 (total improvement model) with models that also included improvement in individual symptoms. RESULTS: For week 6 response, the area under the receiver operating characteristic curve and negative and positive predictive values of the total improvement model were 0.73, 0.67 and 0.74 compared with 0.77, 0.70 and 0.71 for the item improvement model. Model performance decreased for week 12 outcomes. Of predicted non-responders, 29% actually did respond by week 6 and 43% by week 12, which was decreased from the baseline (overall) probabilities of 51% by week 6 and 69% by week 12. In post hoc analyses with continuous rather than dichotomous early improvement, including individual items did not enhance model performance. CONCLUSIONS: Examining individual symptoms adds little to the predictive ability of early improvement. Additionally, early non-improvement does not rule out response or remission, particularly after 12 rather than 6 weeks. Therefore, our findings suggest that routinely adapting pharmacological treatment because of limited early improvement would often be premature.Declaration of interestNone.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. de Vries YA, Roest AM, Bos EH, et al. Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis. Br J Psychiatry. 2018. PMID: 29952277. doi:10.1192/bjp.2018.122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。